[Clinical therapy of depressive syndromes with Noxiptilin].
D000275:Adjustment Disorders / Q000188:drug therapy*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy; D003693:Delirium / Q000139:chemically induced; D003702:Delusions / Q000188:drug therapy; D003863:Depression / Q000188:drug therapy*; D003865:Major Depressive Disorder / Q000188:drug therapy; D005076:Exanthema / Q000139:chemically induced; D005260:Female; D006801:Humans; D006998:Hypochondriasis / Q000188:drug therapy; D008875:Middle Aged; D019965:Neurocognitive Disorders / Q000188:drug therapy; D012559:Schizophrenia / Q000188:drug therapy
D000928:Antidepressive Agents
Klinische Behandlung depressiver Syndrome mit Noxiptilin.